治疗低位:对正静性低血压的管理
Spoorthy Kulkarni1,2, Danny Jenkins1,3, Arko Dhar4
1Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
Journal of cardiovascular pharmacology
|July 19, 2024
概括
正静性低血压的管理是复杂的,特别是高血压. 个性化计划和治疗方法,如米多德林和弗鲁德科尔提松是关键,但需要更多的研究,以获得更好的患者结果.
科学领域:
- 心脏病学 心脏病学
- 神经学 神经学
- 老年病的医生 老年病的医生
背景情况:
- 静止性低血压 (OH) 是一种常见的疾病,有多种原因,导致严重的疾病和死亡.
- 在患有失控高血压的患者中,难以控制高血压.
- 有效的管理需要一个全面的方法来改善症状,避免恶化卧底高血压.
研究的目的:
- 概述目前对静止性低血压的管理策略.
- 突出治疗高血压的挑战,特别是高血压患者.
- 确定未来研究和药物开发的领域.
主要方法:
- 关于正静性低血压管理的当前文献的综述.
- 讨论非药物和药物治疗选择.
- 重点是个性化的管理计划和多学科的护理.
主要成果:
- 非药理学策略包括药物审查,患者教育,触发器避免,压缩装置,饮食改变和姿势辅助器.
- 药理选择包括米多德林 (midodrine),弗鲁多科尔提松 (fludrocortisone),皮里多斯蒂格 (pyridostigmine),亚托莫克西丁 (atomoxetine) 和德罗克西多巴 (droxidopa),而约欣宾 (yohimbine) 是正在研究中的药物.
- 许多治疗方法的有效性和安全性的证据有限.
结论:
- 个性化,多学科的方法对于管理正静性低血压至关重要.
- 需要进一步进行强大的临床试验,以改善治疗策略和开发新疗法.
- 解决OH未满足的医疗需求需要更好地了解病理生理学和基于证据的干预措施.
更多相关视频
14:52Computerized Dynamic Posturography for Postural Control Assessment in Patients with Intermittent Claudication
Published on: December 11, 2013
11.4K
06:51Development of an Algorithm to Perform a Comprehensive Study of Autonomic Dysreflexia in Animals with High Spinal Cord Injury Using a Telemetry Device
Published on: July 29, 2016
7.9K
相关概念视频
01:30Alterations in Blood Pressure
1.2K
Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
1.2K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
418
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
418
01:22Heart Failure Drugs: β-Blockers
336
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336
01:23Antihypertensive Drugs: Vasodilators
497
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
497
01:22Heart Failure Drugs: Diuretics
361
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
361
01:18Hypertension and Regulation of Blood Pressure
2.0K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.0K